Quality Assurance: SOP for Internal Quality Audits in Injectable Manufacturing – V 2.0
Standard Operating Procedure for Internal Quality Audits in Injectable Manufacturing
| Department |
Quality Assurance |
| SOP No. |
SOP/QA/181/2025 |
| Supersedes |
SOP/QA/181/2022 |
| Page No. |
Page 1 of 13 |
| Issue Date |
24/06/2025 |
| Effective Date |
26/06/2025 |
| Review Date |
24/06/2026 |
1. Purpose
To define the standard procedure for planning, conducting, reporting, and following up on internal quality audits in the sterile injectable manufacturing facility. The objective is to verify compliance with GMP, internal procedures, and regulatory requirements, ensuring continuous improvement of quality
systems.
2. Scope
This SOP applies to all departments involved in sterile injectable manufacturing including production, quality control, engineering, warehouse, validation, and documentation functions. It encompasses routine, focused, and follow-up audits.
3. Responsibilities
- Audit Coordinator (QA): Plans and schedules audits, assigns auditors, ensures report compilation and closure of audit observations.
- Auditors: Conduct audits objectively and document findings.
- Auditees: Provide access to information, cooperate with auditors, and implement corrective actions.
- Department Heads: Review and respond to audit findings, ensure closure of non-conformities.
4. Accountability
The Head of Quality Assurance is accountable for ensuring that internal audits are conducted as per the approved schedule and that non-conformances are resolved in a timely and effective manner.
5. Procedure
5.1 Preparation of Audit Schedule
- The Audit Coordinator shall prepare an annual internal audit schedule (Annexure-1) at the beginning of the calendar year based on risk assessment and past audit findings.
- The schedule shall be reviewed and approved by the Head QA and communicated to all departments.
5.2 Selection and Training of Auditors
- Auditors shall be selected from QA and trained in auditing principles, GMP guidelines, and applicable regulatory standards.
- They must be independent of the areas being audited.
5.3 Conducting the Audit
- Auditors shall:
- Refer to the checklist (Annexure-2) for each department/process.
- Review documents, observe activities, and interview personnel.
- Record all observations, including non-conformities (NC), observations (OBS), and suggestions (SUG).
5.4 Classification of Findings
- Non-conformities shall be categorized as:
- Critical: Impacting product quality or patient safety.
- Major: Deviation from SOPs, GMP, or documentation norms.
- Minor: Low-risk procedural or documentation lapses.
5.5 Reporting
- Audit Report (Annexure-3) shall be prepared within 5 working days of the audit and submitted to the auditee department and QA Head.
- It shall include summary, classification, and suggested corrective actions.
5.6 Corrective and Preventive Actions (CAPA)
- Auditee departments must submit CAPA plans (Annexure-4) within 10 working days.
- CAPAs must include root cause analysis, corrective measures, and preventive steps.
5.7 Follow-Up and Closure
- QA shall verify implementation of CAPAs through:
- Review of records
- Follow-up audits if necessary
- Closure of each audit shall be recorded in the Audit Closure Log (Annexure-5).
5.8 Documentation and Retention
- All audit-related documents shall be retained for a minimum of 5 years.
- They must be available for external audits and inspections.
6. Abbreviations
- SOP: Standard Operating Procedure
- QA: Quality Assurance
- NC: Non-Conformance
- CAPA: Corrective and Preventive Action
- GMP: Good Manufacturing Practice
7. Documents
- Internal Audit Schedule – Annexure-1
- Audit Checklist – Annexure-2
- Audit Report – Annexure-3
- CAPA Form – Annexure-4
- Audit Closure Log – Annexure-5
8. References
- WHO TRS 986 Annex 2 – GMP for Sterile Pharmaceutical Products
- ICH Q10 – Pharmaceutical Quality System
- 21 CFR Part 211 – cGMP Regulations
9. SOP Version
Version: 2.0
10. Approval Section
|
Prepared By |
Checked By |
Approved By |
| Signature |
|
|
|
| Date |
|
|
|
| Name |
|
|
|
| Designation |
QA Executive |
QA Manager |
Head QA |
| Department |
Quality Assurance |
Quality Assurance |
Quality Assurance |
11. Annexures
Annexure-1: Internal Audit Schedule
| Department |
Scheduled Date |
Auditor(s) |
| Production |
15/01/2025 |
Sunita Reddy |
| QC |
20/01/2025 |
Rajesh Kumar |
Annexure-2: Audit Checklist
| Area |
Audit Point |
Compliant (Y/N) |
Remarks |
| Documentation |
Batch records updated in real-time |
Y |
|
Annexure-3: Audit Report
| Date |
Department |
Auditor |
Findings |
Classification |
| 15/01/2025 |
Production |
Sunita Reddy |
Missing calibration record |
Major |
Annexure-4: CAPA Form
| Finding |
Root Cause |
Corrective Action |
Preventive Action |
Responsible |
| Missing calibration |
Oversight |
Recalibrated equipment |
Monthly log audit |
Rajesh Kumar |
Annexure-5: Audit Closure Log
| Audit Date |
Department |
Closure Date |
Verified By |
| 15/01/2025 |
Production |
25/01/2025 |
QA Manager |
Revision History:
| Revision Date |
Revision No. |
Details |
Reason |
Approved By |
| 01/01/2022 |
1.0 |
Initial release |
New SOP |
QA Head |
| 24/06/2025 |
2.0 |
Updated checklist and annexures |
Periodic Review |
QA Head |